Authors




Keith Loria

Latest:

Veterinarians and Pharmacists Discuss Challenges Around Pet Medications

Veterinarians and veterinarian pharmacists weigh in on issues around working with pet medications.




Frieda Wiley

Latest:

Independent Pharmacy’s Best Kept Secret in Administering COVID-19 Vaccines

Store owners offer tips for supplying and giving shots.


Gretchen Cuda Kroen

Latest:

Anticoagulants Improve Survival Rates in Patients With COVID-19

Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants.


Bob Kronemyer

Latest:

VMS Frequency Reduced Considerably by Drug Elinzanetant

A recent clinical trial showed positive results from the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer) against menopausal vasomotor symptoms.


Razwan Miah, BPS, PharmD Candidate

Latest:

Reevaluating the Use of Silver Sulfadiazine Cream in the Management of Burns

One antimicrobial agent commonly used in the management of burns is silver sulfadiazine.


Lauren Biscaldi, MS, Managing Editor

Latest:

FDA Approves Omalizumab Injection for Treatment of Food Allergies

The approval was based on positive data from a phase 3 trial that showed patients treated with omalizumab were significantly more likely to tolerate peanut, milk, egg, or cashew protein without moderate to severe allergic symptoms.



Raj Chovatiya, MD, PhD

Latest:

Addressing Patients Adherence with Topical Therapies

Education, honesty, and communication skills are key when it comes to creating treatment regimens.


Leah C. Leszcynski, PharmD

Latest:

Oliceridine (Olinvyk) Offers New Treatment Option for Acute Pain Management in Hospitals and Controlled Clinical Settings

Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.



National Association of Medication Access & Patient Safety

Latest:

What is a Patient Advocate?

Health care advocates provide a vital service for patients who are managing chronic conditions.


dvm360 Staff

Latest:

FDA Approves Broad Spectrum Parasite Protection for Cats

The NexGard COMBO topical solution from Boehringer Ingelheim helps protect cats from tapeworms and other intestinal parasites like fleas, ticks, and heartworms.


Fazila Rajab, MD

Latest:

What You Need to Know About the Albuterol Shortage

The FDA is working quickly to address shortages of the form used in nebulizers.


Roma Sharma

Latest:

How to Help Make Health Equity a Reality

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.


Jasmine Tankard, PharmD Candidate 2021

Latest:

Azacitidine Tablets for Acute Myeloid Leukemia

The FDA approved azacitidine tablets (Onureg; Celgene Corporation) on September 1, 2020


Hayden E. Klein

Latest:

Diabetes Health Outcomes Could be Improved by Lowering Cardiometabolic Drug Costs

As acute and chronic diabetes complications increase, particularly among younger and socioeconomically disadvantaged populations, out-of-pocket costs remain a barrier to accessing essential medications.


Roy Walton, PharmD candidate

Latest:

Daridorexant Receives Approval for Insomnia Treatment

Daridorexant demonstrated significant reduction in daytime sleepiness among other measures.


James B. Leonard, PharmD, DABAT

Latest:

Case Study: Treating Infants for Cannabis Exposure

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.



Charmaine Yuan

Latest:

Current and Future Treatments for Hidradenitis Suppurativa

Hidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.


Bennett Waxse, MD, PhD

Latest:

Examining the US Response to the Mpox Outbreak

By way of natural immunity, vaccination, and behavior change, the majority of the 30,861 documented cases and 54 deaths were confined to 2022, and the epidemic curve portrays a picture of success.


Cassi Prosper, CPhT

Latest:

USP <797> Updated Guidelines

The long-awaited revised USP <797> guidelines will become official on November 1, 2023.


Nicolette Bruno, BPS, PharmD Candidate

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Lisette Hilton

Latest:

Medical Misinformation Consequences in Health Care

The COVID-19 pandemic and social media have resulted in extreme levels of misinformation.


Megan Gray, PharmD

Latest:

Relyvrio: A New FDA-Approved Treatment for Patients With ALS

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.


Douglas Newton, MD, MPH

Latest:

Navigating and Treating 'New Year Depression' in Patients

There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.

© 2024 MJH Life Sciences

All rights reserved.